Business
PDMR Acquisition of Shares
PDMR Acquisition of Shares.
About this update from Shield Therapeutics Plc
[{"type":"text","content":"\n \nRNS Number : 3136X Shield Therapeutics PLC 26 April 2019 \n\nShield Therapeutics plc\n(\"Shield\" or the \"Company\")\n \nPDMR Acquisition of Shares\n \nLondon, UK, 26 April 2019, Shield Therapeutics plc (LSE:STX), a commercial stage pharmaceutical company with a focus on addressing iron deficiency with or without anaemia via its lead product Feraccru®, announces that Mark Sampson, Chief Medical Officer, has acquired 22,875 Ordinary Shares in the Company on 25 April 2019 at an average price of 87.4 pence per share. Mrs Julie Sampson, wife of Mark Sampson, also acquired 22,042 Ordinary Shares in the Company on 25 April 2019 at an average price of 90.7 pence per share. Following the transaction, Dr Sampson has a beneficial interest (including those of his connected persons) in 83,701 shares, representing 0.01% of the Company's issued share capital.\n \nThe notification below, which has been made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.\n \nNotification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them\n \n\n\n\n\n1\n\n\nDetails of the person discharging managerial responsibilities/person closely associated\n \n\n\n\n\na)\n\n\nName\n \n\n\nMark Raymond Sampson\n \n\n\n\n\n2\n\n\nReason for the notification\n \n\n\n\n\na)\n\n\nPosition/status\n \n\n\nChief Medical Officer\n\n\n\n\nb)\n\n\nInitial notification/ Amendment\n \n\n\nInitial Notification\n\n\n\n\n3\n\n\nDetails of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor\n \n\n\n\n\na)\n\n\nName\n \n\n\nShield Therapeutics plc\n\n\n\n\nb)\n\n\nLEI\n \n\n\n213800G74QWY15FC3W71\n\n\n\n\n4\n\n\nDetails of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted\n \n\n\n\n\na)\n\n\nDescription of the financial instrument, type of instrument\n \n \n \n \n \nIdentification code\n \n\n\nOrdinary shares of 1.5p each in the capital of the Company\n \n \n \n \n \n \n \n \n \nISIN of Ordinary Shares: GB00BYV81293\n\n\n...